CNP: Stock thesis & analysis
As of 09-01-2026
📁 From our research archive: this thesis was generated on 09-01-2026 and may not reflect our current view. See the latest research →
CenterPoint is a regulated utility with modest ROE (9.83%), negative FCF margin, and elevated leverage (D/E 210%) — quality metrics that lag typical durable-compounder standards, and the stock trades at 23.6x earnings despite that. Coverage is thin — under-followed, 1 tracked holder — consistent with a large regulated utility simply falling outside quant/hedge-fund mandates rather than any fragility marker, but the business itself does not clear our quality bar at this price. The binding constraint is macro: Utilities rank last (11 of 11) of sectors in a RISK_ON regime that explicitly underweights the sector, and there is no stock-specific catalyst strong enough to override that drag.
Catalysts to watch
- Potential rate-case decisions affecting allowed ROE over the next 2-3 quarters
- Capex/regulatory clarity on grid resiliency spending that could improve FCF trajectory
- Sector rotation back toward defensives if risk-on regime cools
Key risks
- Utilities sector is ranked last of 11 sectors in the current risk-on regime, creating a persistent relative headwind
- High leverage (D/E 210%) and negative FCF margin leave limited balance-sheet flexibility if rates stay elevated
- Valuation (23.6x P/E) is rich relative to ROE of under 10%, leaving little margin for multiple compression
- Thin institutional confirmation (1 tracked fund) limits corroborating signal on positioning
What would change the view
- Stock breaks below $34.50 (below 52wk support / -13% from current)
- D/E rises above 230% without a corresponding rate-case recovery approval
- FCF margin remains negative for 3+ consecutive quarters with no credible path to breakeven